Cover Image
市場調查報告書

全球生物植入市場:各國 (美國、加拿大、印度、中國、日本、英國) 、企業簡介、佔有率、趨勢、分析、機會、市場區隔,及2015∼2021年的預測

Global Bio-Implant Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 348150
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球生物植入市場:各國 (美國、加拿大、印度、中國、日本、英國) 、企業簡介、佔有率、趨勢、分析、機會、市場區隔,及2015∼2021年的預測 Global Bio-Implant Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年04月19日 內容資訊: 英文 140 Pages
簡介

全球生物植入市場,預計2015∼2021年以年複合成長率8%擴大。該市場由於心血管疾病,冠狀動脈心臟病(冠心病)等罹患率上升而擴大。再加上耳植入,心律調節器,其他生物植入的認識提高也大幅擴大全球的市場。

本報告提供全球生物植入市場相關調查、市場概要與至2021年的成長預測、產業趨勢、各地區、各市場區隔趨勢,及主要企業的簡介等彙整。

第1章 歷史的資料

第2章 至2021年的收益預測、成長率、年複合成長率

第3章 產業分析

第4章 競爭分析

第5章 各地區成長資料

  • 簡介
  • 市場概要
    • 市場定義和範圍
    • 主要調查結果
    • 指標分析
    • 主要市場概要
    • 競爭情報
    • 價值鏈分析
    • 主要的購買標準
    • 策略性建議
    • 策略性結論
  • 市場決策因素
    • 推動市場的要素
    • 阻礙市場的要素
    • 市場課題
    • 市場機會
  • 部門分析
  • 市場區隔
    • 各材料
    • 各類型
      • 心血管植入
      • 脊椎移植
      • 整形外科、外傷植入
      • 人工植牙
      • 眼科植入
      • 神經刺激植入
      • 其他
  • 競爭環境
    • 市場佔有率
    • 策略
  • 各地區分析
    • 北美
    • 歐洲
    • 亞太地區
    • 其他
  • 企業簡介

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HME-1411015

The global bio-implants market is driven by various factors which include global rise in adoption of bio-implants, increase in number of people suffering from disabilities. It is giving rise to higher number of amputation. Rising incidence and prevalence rate of CVD, CHD and other heart diseases is also driving the market growth. Additionally, with increasing adoption of prosthetic limbs across geographies and rise in awareness about ear implants, pacemakers and other bio-implants are creating huge scope for global bio-implant market.

Market is segmented on the basis of materials which include material such as ceramics, metal, alloys, polymers and others. Global bio-implant market by material and its type are extensively adopted by major hospitals and clinics for bio-implants. Further the market is segmented on the basis of bio implants type which includes CVD implants, spinal implants, orthopedic and trauma, dental, ophthalmic and neurostimulators. Stents, cardiac implant, ear implant are expected to contribute highest among all the segments of global bio-implant market. With the advancement in technology and innovation due to research and development segments such as dental implants, orthopedic implants are expected to contribute better in next few years.

In terms of geographical segmentation, North America is expected to lead the revenue in this market due to higher adoption of bio-implants such as cochlear implant, prosthetic implants, stents and so on followed by Europe. Asia Pacific market is expected to have the highest market growth. It is driven by growing awareness, rise in number of local manufacturers providing cheaper implants, availability of raw materials such as ceramics, metal and alloys in abundance and growing R&D.

Bio-implant market consists of some major companies which includes Medtronic Inc, Abbot laboratories, AAP implantate AG, Bausch & Lomb incorporated, Biomet Inc, Biotronik SE & Co. KG, Boston scientific corporation, Crook group Inc, CR Bard Inc, Toshiba Corporation and others.

Companies profiled include

  • 1. Medtronic Inc
  • 2. Abbot laboratories
  • 3. AAP implantate AG
  • 4. Bausch & Lomb incorporated
  • 5. Biomet Inc
  • 6. Biotronik SE & Co. KG
  • 7. Boston scientific corporation
  • 8. Crook group Inc
  • 9. CR Bard Inc
  • 10. Toshiba Corporation
  • 11. GE healthcare
  • 12. Edwards lifesciences corporation
  • 13. Endo health solutions Inc
  • 14. Johnson & Johnson
  • 15. Philips corporation
  • 16. Stryker corporation
  • 17. Integral lifesciences holdings corporation
  • 18. Integrated orbital implants
  • 19. Lifenet health Inc
  • 20. Mimedx group Inc
  • 21. Orthofix international N.V.
  • 22. Smith & nephew, PLC
  • 23. Zimmer holdings
  • 24. Wright medical group incorporated
  • 25. WL Gore & associates Inc
  • 26. Tornier N.V.
  • 27. Thoratec corporation
  • 28. St. Jude medical Inc
  • 29. Sorin S.P.A.
  • 30. Intuitive surgicals

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR up to 2021
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data

Table of Contents

1. Introduction

  • 1.1. Executive summary
  • 1.2. Estimation methodology

2. Market overview

  • 2.1. Market definition and scope
  • 2.2. Key findings
  • 2.3. Parametric analysis
    • 2.3.1. Incidence and prevalence rate of amputees
    • 2.3.2. Adoption of artificial leg implant across geographies
    • 2.3.3. Adoption of artificial arm implant across geographies
    • 2.3.4. Adoption of ear implant across geographies
    • 2.3.5. Growing healthcare expenditure across geographies
  • 2.4. Key market insights
    • 2.4.1. Top 3 emerging countries
    • 2.4.2. Top 3 revenue generating segments
    • 2.4.3. Top growing markets and emerging trends
    • 2.4.4. R&D scenario in global bio-implant market
  • 2.5. Competitive intelligence
    • 2.5.1. Market share analysis
    • 2.5.2. Top winning strategies
    • 2.5.3. Case studies: top competitive moves
  • 2.6. Value chain analysis
  • 2.7. Key buying criteria
  • 2.8. Strategic recommendation
  • 2.9. Strategic conclusions

3. Market determinants

  • 3.1. Market drivers
    • 3.1.1. Global rise in adoption of bio-implant increasing the market
    • 3.1.2. Global increase in disabilities giving rise to bio-implant market
    • 3.1.3. Rise incidence and prevalence rate of CVD, CHD and other heart diseases
    • 3.1.4. Innovation giving rise to global bio-implant market
    • 3.1.5. Technological advancement driving the global bio-implant market
    • 3.1.6. Increase in research and development driving global bio-implant market
    • 3.1.7. Rise in minimally invasive surgeries driving global bio-implant market
  • 3.2. Market restraints
    • 3.2.1. High cost of bio-implants creating hurdles in the growth of global bio-implant market
    • 3.2.2. Reimbursement issues may affect the global bio-implant market
  • 3.3. Market challenges
    • 3.3.1. Emerging markets are price sensitive which may affect the global extension of global bio-implant market
    • 3.3.2. Huge costs are associated with every bio-implant which is a concern
  • 3.4. Market opportunities
    • 3.4.1. Increase in adoption of non-surgical or minimally invasive surgical implants
    • 3.4.2. Untapped APAC region has huge scope for global inorganic scintillators market
    • 3.4.3. Increasing awareness about cosmetic implants giving rise to global bio-implant market

4. Sector Analysis

  • 4.1. Parent market
  • 4.2. Sub-segment market
  • 4.3. Alternative market

5. Market Segmentation

  • 5.1. Global bio-implant market by material 2014-2021 ($ million)
    • 5.1.1. Global ceramics market 2014-2021 ($ million)
    • 5.1.2. Global biomaterial metal market 2014-2021 ($ million)
    • 5.1.3. Global alloys market 2014-2021 ($ million)
    • 5.1.4. Global polymers market 2014-2021 ($ million)
    • 5.1.5. Global biological materials market 2014-2021 ($ million)
  • 5.2. Global bio-implant market by material by type 2014-2021 ($ million)
    • 5.2.1. Global cardiovascular implant market 2014-2021 ($ million)
      • 5.2.1.1. Global pacing device market 2014-2021 ($ million)
        • 5.2.1.1.1. Global cardiac resynchronization therapy device market 2014-2021 ($ million)
        • 5.2.1.1.2. Global implantable cardioverter defibrillators (ICDs) market 2014-2021 ($ million)
        • 5.2.1.1.3. Global implantable cardiac pacemaker market 2014-2021 ($ million)
        • 5.2.1.1.4. Global pacing accessories market 2014-2021 ($ million)
      • 5.2.1.2. Global stents implants market 2014-2021 ($ million)
        • 5.2.1.2.1. Global coronary stent market 2014-2021 ($ million)
        • 5.2.1.2.2. Global peripheral stents market 2014-2021 ($ million)
        • 5.2.1.2.3. Global stent related implant market 2014-2021 ($ million)
      • 5.2.1.3. Global structural cardiac implant market 2014-2021 ($ million)
        • 5.2.1.3.1. Global heart valves and accessories market 2014-2021 ($ million)
        • 5.2.1.3.2. Global ventricular assist market 2014-2021 ($ million)
        • 5.2.1.3.3. Global implantable heart monitor market 2014-2021 ($ million)
    • 5.2.2. Global spinal implants market 2014-2021 ($ million)
      • 5.2.2.1. Global horacolumbar implants market 2014-2021 ($ million)
      • 5.2.2.2. Global intervertebral spacers market 2014-2021 ($ million)
      • 5.2.2.3. Global machined allograft spacers market 2014-2021 ($ million)
      • 5.2.2.4. Global cervical implants market 2014-2021 ($ million)
      • 5.2.2.5. Global motion preservation implants market 2014-2021 ($ million)
      • 5.2.2.6. Global implantable spinal stimulators market 2014-2021 ($ million)
    • 5.2.3. Global orthopedics & trauma implants market 2014-2021 ($ million)
      • 5.2.3.1. Global reconstructive joint replacement market 2014-2021 ($ million)
      • 5.2.3.2. Global orthobiologics market 2014-2021 ($ million)
      • 5.2.3.3. Global trauma implant market 2014-2021 ($ million)
      • 5.2.3.4. Global sports medicine market 2014-2021 ($ million)
    • 5.2.4. Global dental implants market 2014-2021 ($ million)
      • 5.2.4.1. Global plate form dental implants market 2014-2021 ($ million)
      • 5.2.4.2. Global root form dental implants market 2014-2021 ($ million)
    • 5.2.5. Global ophthalmic implants market 2014-2021 ($ million)
      • 5.2.5.1. Global intraocular lens market 2014-2021 ($ million)
      • 5.2.5.2. Global glaucoma market 2014-2021 ($ million)
    • 5.2.6. Global neurostimulators implants market 2014-2021 ($ million)
      • 5.2.6.1. Global deep brain stimulators market 2014-2021 ($ million)
      • 5.2.6.2. Global sacral nerve stimulators market 2014-2021 ($ million)
      • 5.2.6.3. Global spinal cord stimulators market 2014-2021 ($ million)
      • 5.2.6.4. Global vagus nerve stimulators market 2014-2021 ($ million)
      • 5.2.6.5. Global other stimulators market 2014-2021 ($ million)
    • 5.2.7. Global other implants market 2014-2021 ($ million)
      • 5.2.7.1. Global gynecological device market 2014-2021 ($ million)
      • 5.2.7.2. Global drug implant market 2014-2021 ($ million)
      • 5.2.7.3. Global otolaryngeal implant market 2014-2021 ($ million)
      • 5.2.7.4. Global cosmetic implant market 2014-2021 ($ million)
      • 5.2.7.5. Global gastroenterological implant market 2014-2021 ($ million)
      • 5.2.7.6. Global urological implant market 2014-2021 ($ million)
      • 5.2.7.7. Global skin & wound care implant market 2014-2021 ($ million)

6. Competitive Landscape

  • 6.1. Market share
  • 6.2. Strategy - An analysis across tiers

7. Geographical analysis

  • 7.1. North America bio-implant market 2014-2021 ($ million)
    • 7.1.1. United States (U.S.) bio-implant market 2014-2021 ($ million)
    • 7.1.2. Canada bio-implant market 2014-2021 ($ million)
  • 7.2. Europe bio-implant market 2014-2021 ($ million)
    • 7.2.1. United Kingdom (UK) bio-implant market 2014-2021 ($ million)
    • 7.2.2. France bio-implant market 2014-2021 ($ million)
    • 7.2.3. Germany bio-implant market 2014-2021 ($ million)
    • 7.2.4. Spain bio-implant market 2014-2021 ($ million)
    • 7.2.5. Italy bio-implant market 2014-2021 ($ million)
    • 7.2.6. RoE bio-implant market 2014-2021 ($ million)
  • 7.3. Asia Pacific bio-implant market 2014-2021 ($ million)
    • 7.3.1. India bio-implant market 2014-2021 ($ million)
    • 7.3.2. China bio-implant market 2014-2021 ($ million)
    • 7.3.3. Japan bio-implant market 2014-2021 ($ million)
    • 7.3.4. Korea bio-implant market 2014-2021 ($ million)
    • 7.3.5. Australia bio-implant market 2014-2021 ($ million)
    • 7.3.6. RoAPAC bio-implant market 2014-2021 ($ million)
  • 7.4. Rest of the world bio-implant market 2014-2021 ($ million)
    • 7.4.1. Latin America bio-implant market 2014-2021 ($ million)
    • 7.4.2. MENA bio-implant market 2014-2021 ($ million)
    • 7.4.3. Africa bio-implant market 2014-2021 ($ million)

8. Company Profiles

  • 8.1. Medtronic Inc
  • 8.2. Abbot laboratories
  • 8.3. AAP implantate AG
  • 8.4. Bausch & Lomb incorporated
  • 8.5. Biomet Inc
  • 8.6. Biotronik SE & Co. KG
  • 8.7. Boston scientific corporation
  • 8.8. Crook group Inc
  • 8.9. CR Bard Inc
  • 8.10. Toshiba Corporation
  • 8.11. GE healthcare
  • 8.12. Edwards lifesciences corporation
  • 8.13. Endo health solutions Inc
  • 8.14. Johnson & Johnson
  • 8.15. Philips corporation
  • 8.16. Stryker corporation
  • 8.17. Integral lifesciences holdings corporation
  • 8.18. Integrated orbital implants
  • 8.19. Lifenet health Inc
  • 8.20. Mimedx group Inc
  • 8.21. Orthofix international N.V.
  • 8.22. Smith & nephew, PLC
  • 8.23. Zimmer holdings
  • 8.24. Wright medical group incorporated
  • 8.25. WL Gore & associates Inc
  • 8.26. Tornier N.V.
  • 8.27. Thoratec corporation
  • 8.28. St. Jude medical Inc
  • 8.29. Sorin S.P.A.
  • 8.30. Intuitive surgicals
Back to Top